Benzinga | Jul 27, 2020 08:25AM EDT

Jefferies Maintains Buy on Immunomedics, Raises Price Target to $55

Jefferies maintains Immunomedics (NASDAQ:IMMU) with a Buy and raises the price target from $41 to $55.